obesity race

After a steady stream of GLP-1 data last week, the news kept flowing this week when Sciwind Biosciences got clearance from Chinese regulators for its GLP-1 injectable for obesity. Pfizer will commercialize the drug in that country following a deal last month. But the obesity attention this week was more focused on the amylin front. The mechanism, which some […]